| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity of trastuzumab emtansine (T-DM1) in 3D cell culture
|
Boyer, Jean Zheng
|
|
|
188 |
1 |
p. 65-75
|
article
|
| 2 |
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors
|
Kim, Kyae Hyung
|
|
|
188 |
1 |
p. 203-214
|
article
|
| 3 |
Barriers and engagement in breast cancer survivorship wellness activities
|
Szuhany, Kristin L.
|
|
|
188 |
1 |
p. 317-325
|
article
|
| 4 |
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry
|
Kaufman, Peter A.
|
|
|
188 |
1 |
p. 179-190
|
article
|
| 5 |
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study
|
Chetrit, Angela
|
|
|
188 |
1 |
p. 273-282
|
article
|
| 6 |
Characterization of estrogen receptor-low-positive breast cancer
|
Fei, Fei
|
|
|
188 |
1 |
p. 225-235
|
article
|
| 7 |
Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer
|
Ahn, Sung Gwe
|
|
|
188 |
1 |
p. 165-178
|
article
|
| 8 |
Comparison of mastectomy and breast reconstruction outcomes using low thermal dissection versus traditional electrocautery: a blinded randomized trial
|
Habibi, Mehran
|
|
|
188 |
1 |
p. 101-106
|
article
|
| 9 |
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS
|
Rakovitch, Eileen
|
|
|
188 |
1 |
p. 133-139
|
article
|
| 10 |
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
|
Masuda, Norikazu
|
|
|
188 |
1 |
p. 117-131
|
article
|
| 11 |
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA
|
Sundaresan, Tilak K.
|
|
|
188 |
1 |
p. 43-52
|
article
|
| 12 |
Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study
|
Lizarraga, Ingrid M.
|
|
|
188 |
1 |
p. 191-202
|
article
|
| 13 |
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
|
Battisti, Nicolò Matteo Luca
|
|
|
188 |
1 |
p. 149-163
|
article
|
| 14 |
LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis
|
Wang, You-Quan
|
|
|
188 |
1 |
p. 1-14
|
article
|
| 15 |
Male and female breast cancer: the two faces of the same genetic susceptibility coin
|
Silva, Susana Nunes
|
|
|
188 |
1 |
p. 295-305
|
article
|
| 16 |
Mammography use and breast cancer incidence among older U.S. women
|
Turbow, Sara D.
|
|
|
188 |
1 |
p. 307-316
|
article
|
| 17 |
Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women
|
Luo, Juhua
|
|
|
188 |
1 |
p. 283-293
|
article
|
| 18 |
M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma
|
Arole, Vidya
|
|
|
188 |
1 |
p. 37-42
|
article
|
| 19 |
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
|
Park, Ko Un
|
|
|
188 |
1 |
p. 249-258
|
article
|
| 20 |
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting
|
Almodallal, Yahya
|
|
|
188 |
1 |
p. 15-20
|
article
|
| 21 |
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI
|
Tokuda, Yukiko
|
|
|
188 |
1 |
p. 107-115
|
article
|
| 22 |
Prosigna test in breast cancer: real-life experience
|
Hequet, D
|
|
|
188 |
1 |
p. 141-147
|
article
|
| 23 |
Reply to the letter on sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer
|
Damin, Andrea P.
|
|
|
188 |
1 |
p. 327-328
|
article
|
| 24 |
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES
|
Im, Young-Hyuck
|
|
|
188 |
1 |
p. 77-89
|
article
|
| 25 |
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
|
Chalasani, Pavani
|
|
|
188 |
1 |
p. 91-99
|
article
|
| 26 |
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing
|
Lertwilaiwittaya, Pongtawat
|
|
|
188 |
1 |
p. 237-248
|
article
|
| 27 |
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies
|
Smith, Samuel G.
|
|
|
188 |
1 |
p. 215-223
|
article
|
| 28 |
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
|
Al-Kawaz, Abdulbaqi
|
|
|
188 |
1 |
p. 53-63
|
article
|
| 29 |
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies
|
Dempsey, Naomi
|
|
|
188 |
1 |
p. 21-36
|
article
|
| 30 |
Variations in breast cancer surgical treatment and timing: determinants and disparities
|
Dankwa-Mullan, Irene
|
|
|
188 |
1 |
p. 259-272
|
article
|
Journal description